Furthermore, nintedanib and pirfenidone decreased invadosome formation by IPF fibroblasts, with nintedanib concomitantly inhibiting TKS5 expression and the PDGFR/Akt axis. Here, SH3PXD2A is linked to idiopathic pulmonary fibrosis.